The trends are partly attributable to increased use of prostate-specific antigen (PSA) testing (Brewster et al, 2000), which identifies some cancers that would otherwise have remained asymptomatic and nonlethal (Pashayan et al, 2006a, 2006b). The gene discussed is KLK3; the disease is cancer.